TSE:BHC Bausch Health Companies (BHC) Stock Price, News & Analysis C$9.04 -0.03 (-0.33%) As of 02/13/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades About Bausch Health Companies Stock (TSE:BHC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BHC alerts:Sign Up Key Stats Today's RangeC$8.96▼C$9.1150-Day RangeC$9.05▼C$11.9852-Week RangeC$5.45▼C$15.43Volume256,165 shsAverage Volume246,767 shsMarket CapitalizationC$2.35 billionP/E RatioN/ADividend Yield0.76%Price TargetC$9.00Consensus RatingHold Company OverviewBausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Read More… Bausch Health Companies Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks16th Percentile Overall ScoreBHC MarketRank™: Bausch Health Companies scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingBausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageBausch Health Companies has received no research coverage in the past 90 days.Read more about Bausch Health Companies' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Companies is -13.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Companies is -13.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BHC. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldBausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBausch Health Companies does not have a long track record of dividend growth.Read more about Bausch Health Companies' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for BHC. News and Social Media1.6 / 5News Sentiment-0.05 News SentimentBausch Health Companies has a news sentiment score of -0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Bausch Health Companies this week, compared to 2 articles on an average week.Search Interest13 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 8% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Bausch Health Companies insiders have not sold or bought any company stock.Percentage Held by Insiders11.28% of the stock of Bausch Health Companies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions79.01% of the stock of Bausch Health Companies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bausch Health Companies' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. Email Address BHC Stock News HeadlinesBausch Health Companies Inc.: Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars ProgramFebruary 10, 2025 | finanznachrichten.deBausch Health Companies (BHC) Gets a Hold from Truist FinancialFebruary 8, 2025 | markets.businessinsider.comMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.February 14, 2025 | Brownstone Research (Ad)Jefferies Downgrades Bausch Health Companies (BHC)February 8, 2025 | msn.comJefferies cuts Bausch Health stock rating to hold, target to $8February 6, 2025 | msn.comBausch Health downgraded at Jefferies with B+L deal catalyst removedFebruary 6, 2025 | markets.businessinsider.comBausch Health Companies Inc.: Bausch Health Provides Update on Strategic AlternativesFebruary 6, 2025 | finanznachrichten.deBausch + Lomb Talks With Suitor Doesn't Result in Deal -- UpdateFebruary 6, 2025 | marketwatch.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Companies' stock was trading at C$11.62 on January 1st, 2025. Since then, BHC stock has decreased by 22.2% and is now trading at C$9.04. View the best growth stocks for 2025 here. How do I buy shares of Bausch Health Companies? Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Bausch Health Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolTSE:BHC CUSIPN/A CIKN/A Webwww.valeant.com Phone514-744-6792FaxN/AEmployees19,900Year FoundedN/APrice Target and Rating Average Stock Price TargetC$9.00 High Stock Price TargetC$9.00 Low Stock Price TargetC$9.00 Potential Upside/Downside-0.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.68) Trailing P/E RatioN/A Forward P/E Ratio1.63 P/E Growth0.21Net IncomeC$-125,650,969.23 Net Margins-1.88% Pretax MarginN/A Return on Equity15.87% Return on Assets4.16% Debt Debt-to-Equity Ratio-1,831.94 Current Ratio1.19 Quick Ratio0.58 Sales & Book Value Annual SalesC$6.69 billion Price / Sales0.35 Cash FlowC$1.17 per share Price / Cash Flow7.76 Book ValueC($0.66) per share Price / Book-13.76Miscellaneous Outstanding Shares260,055,152Free FloatN/AMarket CapC$2.35 billion OptionableNot Optionable Beta0.77 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (TSE:BHC) was last updated on 2/14/2025 by MarketBeat.com Staff From Our Partners*Breaking News!* This Pharma NASDAQ Company and the U.S Army!!! This Little Known NASDAQ Company just released positive results from its drugs that have been undergoing testi...Trading Wire | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | Sponsored[RFK Jr CONFIRMED] But Will THIS Be His DownfallRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s #1 investment during Trump’s termWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump Policies Are Going to Light a Fire Under GoldHow You Can Profit from Trump's Bold Moves in 2025 Donald Trump’s bold policies are creating unprecedented ...Golden Portfolio | Sponsored New Options "Trading GPS" = 91% Win-RateThink of it as GPS navigation for the options market... Even traders who previously found options "too comp...Eagle Publishing | SponsoredMust-See: Trump’s Shocking AI AnnouncementIf you have any investments in AI stocks or are interested in AI… Please take a moment to review the detail...Brownstone Research | SponsoredElon has entered the MarkBeat conversationSpivey's firm accurately warned of both the 2008 and 2020 stock market crashes and have charged institutional ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.